These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Compound heterozygous SCN5A mutations: does the sum of the parts equal the whole? Benson DW Heart Rhythm; 2009 Aug; 6(8):1176-7. PubMed ID: 19560406 [No Abstract] [Full Text] [Related]
30. Mutations in the SCN5A gene: evidence for a link between long QT syndrome and sudden death? Kiehne N; Kauferstein S Forensic Sci Int Genet; 2007 Jun; 1(2):170-4. PubMed ID: 19083750 [TBL] [Abstract][Full Text] [Related]
31. Look beyond the hERG mutation: a neutral SCN5A variant may turn lidocaine into a threat. Lindegger N; Mongillo M Heart Rhythm; 2008 Nov; 5(11):1575-6. PubMed ID: 18984535 [No Abstract] [Full Text] [Related]
32. Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome. Clancy CE; Tateyama M; Kass RS J Clin Invest; 2002 Nov; 110(9):1251-62. PubMed ID: 12417563 [TBL] [Abstract][Full Text] [Related]
33. Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. Bai R; Napolitano C; Bloise R; Monteforte N; Priori SG Circ Arrhythm Electrophysiol; 2009 Feb; 2(1):6-15. PubMed ID: 19808439 [TBL] [Abstract][Full Text] [Related]
34. Single-nucleotide polymorphisms in SCN5A gene in Chinese Han population and their correlation with cardiac arrhythmias. Chen J; Xie X; Zhu J; Tao Q; Wang X Genet Med; 2004; 6(3):159. PubMed ID: 15354335 [No Abstract] [Full Text] [Related]
35. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes. Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580 [TBL] [Abstract][Full Text] [Related]
36. Atrial arrhythmogenicity in aged Scn5a+/DeltaKPQ mice modeling long QT type 3 syndrome and its relationship to Na+ channel expression and cardiac conduction. Guzadhur L; Pearcey SM; Duehmke RM; Jeevaratnam K; Hohmann AF; Zhang Y; Grace AA; Lei M; Huang CL Pflugers Arch; 2010 Aug; 460(3):593-601. PubMed ID: 20552221 [TBL] [Abstract][Full Text] [Related]
37. Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3. Ruan Y; Denegri M; Liu N; Bachetti T; Seregni M; Morotti S; Severi S; Napolitano C; Priori SG Circ Res; 2010 Apr; 106(8):1374-83. PubMed ID: 20339117 [TBL] [Abstract][Full Text] [Related]
38. Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome. Ackerman MJ; Siu BL; Sturner WQ; Tester DJ; Valdivia CR; Makielski JC; Towbin JA JAMA; 2001 Nov; 286(18):2264-9. PubMed ID: 11710892 [TBL] [Abstract][Full Text] [Related]
39. Sodium channel abnormalities are infrequent in patients with long QT syndrome: identification of two novel SCN5A mutations. Wattanasirichaigoon D; Vesely MR; Duggal P; Levine JC; Blume ED; Wolff GS; Edwards SB; Beggs AH Am J Med Genet; 1999 Oct; 86(5):470-6. PubMed ID: 10508990 [TBL] [Abstract][Full Text] [Related]
40. Congenital long-QT syndrome caused by a novel mutation in a conserved acidic domain of the cardiac Na+ channel. Wei J; Wang DW; Alings M; Fish F; Wathen M; Roden DM; George AL Circulation; 1999 Jun; 99(24):3165-71. PubMed ID: 10377081 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]